Generics 75

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Lornoxicam manufacturers

75 products found

Filters

75 products found

lornoxicam

Tablets 4 mg, 8 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

This CTD dossier owner and manufacturer specializes in the manufacturing, import, and export of a diverse range of healthcare products. Their portfolio includes over 300 registered pharmaceutical products spanning various therapeutic areas, primarily delivered through tablets, capsules, dry suspensions, injectables, and sachets. The company operates a state-of-the-art manufacturing facility equipped with modern technology to ensure high-quality production according to international standards. They are committed to research and development, aiming to provide innovative healthcare solutions globally. Their focus extends beyond manufacturing, encompassing market research and the promotion of pharmaceutical products across regions like the EU and North America.

Manufacturer usually replies in 4 days

lornoxicam

Tablets, film coated 8 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
WHO
Manufacturer #21023

This CTD dossier owner and manufacturer, based in the Middle East and North Africa region, has been operating for several decades. They specialize in manufacturing and marketing a diverse range of pharmaceutical products, including both prescription and over-the-counter medications. The company focuses on providing high-quality generic drugs, with a strong emphasis on cost-effectiveness and meeting the needs of a wide customer base. Their products are distributed in over 10 countries, demonstrating their strong regional presence. The company's manufacturing processes adhere to EU and USA GMP standards, ensuring the quality and safety of their products. Their therapy areas include cardiology and other specialties, though specific details are not publicly available. The company primarily produces solid and liquid dosage forms. Although product patents are not mentioned on the website, their commitment to quality and innovation suggests they are likely involved in patent protection for their formulations.

lornoxicam

Tablets 8 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19698
This pharmaceutical company, established in the region of Asia, has been operating for over four decades. Their product portfolio includes both prescription and over-the-counter medications, encompassing a wide range of therapeutic areas such as pain management, allergies, infections, digestive disorders, and cardiovascular health. The company manufactures various dosage forms, including tablets, capsules, injections, and topical preparations. They have multiple manufacturing facilities in the region and have secured GMP approvals for their production lines, demonstrating a commitment to quality and compliance. Their strong track record in the industry is evidenced by their vast product portfolio, extensive distribution network, and significant turnover. The company also actively engages in research and development, aiming to introduce innovative pharmaceutical solutions to the market.

Want to see all 75 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Lornoxicam Manufacturers

Lornoxicam belongs to a class of new nonsteroidal anti-inflammatory drugs (NSAID) of the oxicam class which is an analgesic with anti-inflammatory and antipyretic properties. Lornoxicam is mainly used for pain relief. Lornoxicam relieves pain and inflammation in conditions like rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Lornoxicam works by blocking the release of the certain chemical messengers which are responsible for the inflammation, pain and swelling. Before using Lornoxicam, the risk of taking the drug must be weighed against the benefits it provides. It is always recommended to consult a physician before taking Lornoxicam as this medication may interact with other drugs or health problems. Manufacturers market Lornoxicam drugs under the Brand name of Acabel, Bosporon, Lorflex, Lorcam. Lornoxicam comes in the dosage form of film-coated tablet which is taken orally and is available in 4 mg and 8 mg dosage strengths. The daily recommended dose of Lornoxicam is 8 -16 mg which is divided into 2 or 3 doses and the maximum daily dose should not exceed 16 mg. Lornoxicam is also available in powder and solvent for solution for injection which is available in dosage strengths of 8 mg administered intramuscularly or intravenously. Daily dose of Lornoxicam injections is 8 mg and the maximum daily dose should not exceed 16 mg. Patients with liver or kidney impairment, should not take more than 12 mg (taken twice or three times a day) of this medicine. For patients with arthritis the recommended dose is 12 mg, divided in two or three doses per day which should not exceed more than 16 mg a day. This Drug Lornoxicam is contraindicated in the patients who must not be taking other NSAIDs, possible reasons which are said to be seen are salicylate sensitivity, gastrointestinal bleeding, and bleeding disorders, with severe impairment of heart, liver and kidney function. Lornoxicam is not at all recommended during pregnancy of the patient and breastfeeding is contraindicated during the last trimester of pregnancy. The approved storage conditions for Lornoxicam are to store at a temperature not above 30° C (86° F).

Wholesale Price of Lornoxicam

In the US market, the wholesale price of Lornoxicam oral tablet 4 mg costs around $ 0.56 for a set of 10 tablets and for a set 100 Lornoxicam oral tablet 4 mg costs around $ 5.6. The cost of Lornoxicam oral tablet 8 mg costs $ 0.91 for a quantity of 10 tablets and for a set 100 Lornoxicam oral tablet 8 mg it costs around $ 9.1. The cost for Lornoxicam 8 mg vial is around $ 36.40 for 5 vials and the cost for lornoxicam 8mg/2ml for 5 vials is $ 46.80.

Lornoxicam - Mechanism of action

Lornoxicam ability of anti-inflammatory and analgesic activity is related mainly to the structure of inhibitory action on prostaglandin and thromboxane synthesis along with the inhibition of both COX-1 and COX-2, which mainly leads to the reduction of inflammation, pain, fever, and swelling, the symptoms which are mainly mediated by prostaglandins.

Finding Lornoxicam Manufacturers and Suppliers

Finding a trustful partner in our business is one of the biggest challenges and to overcome that challenge and to make one’s work / life easy in finding the trusted manufacturer and supplier of Lornoxicam, one can visit the Pipelinepharma website which helps you in finding the trusted manufacturers and suppliers of Lornoxicam. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products which quickly connects owner with the customers for the business development. You can filter the product names in user friendly and unified search engine by its country, category, therapeutic area, forms, dossier and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible